HR 89 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Prescription Freedom Act of 2025
To repeal the authority of the Food and Drug Administration to require that drugs be dispensed only upon prescription, and for other purposes.
Summary
This bill repeals the Food and Drug Administration's federal authority to require that drugs be dispensed only upon prescription, effective six months after enactment. After the effective date, federal references to prescription requirements are redirected to applicable state law, effectively transferring control over prescription requirements to individual states. The bill includes an exception that allows the Secretary of Health and Human Services to continue requiring prescriptions for drugs intended to terminate pregnancy.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
- Rep. Biggs, Andy [R-AZ-5] (R-AZ)
Money behind the sponsor
Top reported contributors to Andy Biggs’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- SAULSBURY INDUSTRIES $9,900
- 21ST CENTURY HEALTHCARE $7,500
- ULINE $6,600
- TW LEWIS COMPANY $6,600
- LEE BENSON $6,600
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Andy Biggs → · Outside spending →
Actions (2)
- Jan 3, 2025 Referred to the House Committee on Energy and Commerce. · house
- Jan 3, 2025 Introduced in House
More bills on these subjects (8)
Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Full text
IN THE HOUSE OF REPRESENTATIVES
January 3, 2025
Mr. Biggs of Arizona introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To repeal the authority of the Food and Drug Administration to require that drugs be dispensed only upon prescription, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Prescription Freedom Act of 2025”.
SEC. 2. REPEAL OF FDA AUTHORITY TO REQUIRE PRESCRIPTIONS.
(a) Repeal.—Effective as of the date that is 6 months after the date of enactment of this Act, subsection (b) of section 503 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353) is repealed.
(b) References.—Beginning on the effective date described in subsection (a), any reference in a Federal statute, regulation, or guidance—
(1) to prescribing, a prescription, a prescription drug, or a drug subject to section 503(b) of the Federal Food, Drug, and Cosmetic Act is deemed to be a reference to prescribing, a prescription, or a prescription drug, respectively, under applicable State law; and
(2) to any requirement or provision of section 503(b) of the Federal Food, Drug, and Cosmetic Act is deemed to be a reference to the corresponding requirement or provision, if any, in applicable State law, as determined by the Federal official or officials responsible for administering the respective Federal statute, regulation, or guidance.
(c) Exception.—Notwithstanding subsections (a) and (b), the Secretary of Health and Human Services may continue to exercise the authority vested by subsection (b) of section 503 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353), as in effect on the day before the effective date described in subsection (a), with respect to any drug that is intended for use in terminating a pregnancy. <all>
Comments